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ABSTRACT 
Introduction: Less than a century ago, Gastric cancer was the most common cancer in the world.  Despite 
its worldwide decline over the past century, it remains a major killer across the globe.  Information on 
gastric cancer in developing countries and especially Africa remains low. 
Aim: Assess prevalence of gastric cancer among patients presenting with dyspepsia 
Methodology: This was a retrospective study to determine the prevalence of gastric cancer among patients 
with dyspepsia referred for upper GI Endoscopy between June 2014 and June 2016.  Source of information 
was reports made at endoscopy.  Patient reports included Age, Gender, reason for referral [presenting 
symptoms], and findings on oesophagus, OG junction, stomach and Duodenum. Biopsy specimens were 
taken from any swellings, erosions, erythematous areas, ulcers and any other abnormal looking areas. They 
were preserved in 10% formal saline and sent for histology.  Reports from histology were then linked to the 
endoscopy reports after reporting. 
Data analysis: Data was analyzed using SPSS version 21.  The analysis included running of frequency tables 
[Descriptive statistics] and cross correlations were calculated using Fishers exact chi square test owing to 
the small sample size. 
Results: One thousand two hundred patients underwent OGD over the 2 years.  Forty four patients seen 
over the 2 years had gastric cancer giving a prevalence of 3.67%.  Twenty seven of the patients with gastric 
cancer were males and 17 were females giving female to male ration of 1.1.8.  Diffuse gastric cancer was the 
most common followed by intestinal type.  Females tended to get gastric cancer at a younger age than males. 
Conclusion: The prevalence of gastric cancer is relatively high.  Males are affected more than females.  
Diffuse gastric cancer is more common like other parts of the world. 
                                                       [Afr J Health Sci. 2017; 31(1):51-59] 
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Introduction 
Less than a century ago, gastric cancer was perhaps 
the most common cancer throughout the world.  It is 
now the 4th most common cancer and the second most 
common cause of cancer related deaths [1-4]. 
Each year, approximately 990,000 people are 
diagnosed with gastric cancer worldwide, of whom 
about 938,000 die from this disease [5].  Gastric 
cancer also causes one of the highest cancer burdens, 
as measured by disability-adjusted life years lost [5]. 
Gastric cancer incidence rates vary widely between 
men and women and across different countries.  In 
many countries, rates are 2 to 3 times higher in men 
than women [5].  Gastric cancer incidence rates have 
been on the decline in many parts of the world except 
Africa.  Gastric cardia cancer has however remained 
relatively unchanged in Western Countries.  This is 
thought not to be related to [Helicobacter pylori] 
infection, a bacterial infection whose prevalence has 
declined greatly in developed countries but is still 
high in developing countries. 
The large majority [Approx. 90%] of gastric cancers 
are adenocarcinomas which arise from the glands of 
the most superficial layer, the mucosa, of the 
stomach.  There are however, other types of cancer 
arising from stomach including mucosa associated 
lymphoid tissue lymphoma which originates from 
lymphoid tissue of the stomach and 
leiomyoscercomas which arise from the muscles that 
surround the mucosa. 
A popular classification by Lauren Stratifies gastric 
cancer [Adenocarcinoma] into 2 major histological 
types, diffuse and intestinal [6].  These two types 
have different appearance histologically, gender 
ratio, age at diagnosis, epidemiologic patterns and 
causes.  Intestinal type of gastric carcinoma is 
associated with H.pylori associated chronic gastritis, 
atrophy and intestinal metaplasia which are thought 
to be precursors of the dysplastic changes that evolve 
into this type of carcinoma [7]. 
Gastric carcinomas of the diffuse type are also 
associated with H. pylori infection, but not with 
atrophy and intestinal metaplasia and are thought to 
have poor prognosis compared to the intestinal type 
Frequencies of the two broad groups of gastric cancer 
also differ.                                                                
Studies done in the past 3 decades support multi-
factorial aetiology of sporadic gastric cancer and 
have led to the concept of progressive cascade of 
phenotypic and molecular changes that may 
eventually lead to neoplasm: Helicobacter Pylori [H. 
pylori] is blamed as a vital aetiological element that 
initiates the entire process of gastritis both H. pylori 
induced and autoimmune in origin, leading to 
mucosal damage. H. pylori induced gastritis, may 
lead to intestinal metaplasia which may progressive 
to intestinal type of cancer.  The diffuse type is 
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usually related to non-atrophic gastritis [8].  Although 
H. pylori is an important aetiologic factor, phenotypic 
expression depends on H. pylori genotype in the 
stomach, notably cytotoxin associated gene [Cag A] 
positive strains [9]. 
Several studies show nutrition contributes 
significantly to gastric cancer.  Many micronutrients 
including minerals like selerum, antioxidant like 
carotenoids Vitamins C, and E are protective against 
gastric cancer.  However, heavy smoking in 
conjunction with alcohol consumption [20 cigarettes/ 
day and more than 5 occasions of heavy alcohol 
intake in 14 days] increases the risk to non-cardia 
gastric adenocarcinoma [10].  High salt diet also 
enhances chemically induced gastric cancer in a dose 
dependent fashion [11].  Nitrosamines and other nitro 
compounds have been found to be carcinogenic in 
animal studies and are also classified as carcinogenic 
to humans.  Meat and fish that are smoked, pickled, 
and salt preserved have been found to have high 
levels of nitro compounds.  High intake of these foods 
could lead to gastric non-cardia adenocarcinoma 
[12].  Obesity with body mass index in excess of 
30kg/m2 does increase the risk of gastric cardia 
adenocarcinoma due to acid reflux [13] 
Other factors associated with stomach cancer include 
environmental, genetic, advanced age, male sex, 
radiation exposure and family history.  Risk factors 
for cancers arising from cardia and non-cardia gastric 
regions are different.  H. pylori is thought to involve 
mainly the non-cardia gastric cancer. 
It has been recognized that there is an upward trend 
in non-communicable disease, including cancer 
within developing countries [14] The World Health 
Organization [WHO] estimates an increase in cancer 
deaths of 45% between the years 2007 and 2030 [15].  
Cancer kills more people than AIDs, tuberculosis and 
malaria combined yet it has received less focus. 
Understanding risk factors, aetiology and 
management of various types of cancer, and in 
particular gastric cancer will impact the survival 
outcomes of those affected by risk or disease. With 
the increasing westernization of diet in our rapidly 
growing urban centers, lifestyles are changing and so 
is the increased risk of cancer of the stomach. [16] 
It is therefore prudent to increase research and 
publications related to cancer in Africa including 
cancer of the stomach. There is however, a paucity of 
published data regarding gastric cancer in Africa and 
the need to elucidate common subtypes and aetiology 
is urgent. 
Aim 
Assess the prevalence of gastric cancer among 
patients presenting with dyspepsia. 
Methodology 
This was a retrospective study to determine the 
prevalence of gastric cancer amongst patients with 
dyspepsia sent for upper gastrointestinal endoscopy 
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in a busy Gastroenterology Clinic in Nairobi, Kenya.  
The patients were referrals from almost all parts of 
Kenya and they all presented with dyspepsia. 
Data Collection 
Data was extracted from records on reports made 
after every endoscopy procedure.  The information 
captured included name, age, gender reason for 
referral, procedure findings from oesophagus, 
gastroesphageal Junction [OG junction], stomach and 
duodenum.  All findings were recorded on a standard 
report forum.   Pictures of any observed lesions were 
captured and printed.  Biopsies were taken from 
abnormal looking lesions/areas, preserved in 10% 
formal saline and sent for histology.  Histology 
reporting was done by a consultant Pathologist  
Data analysis 
Data was analyzed using SPSS version 21.  The 
analysis included running of frequency tables 
[Descriptive Statistics] and cross correlations were 
calculated using Fishers exact test owing to the small 
sample size 
Results 
Data given below is from a collection of gastric 
cancer cases seen in a busy Nairobi gastroenterology 
clinic over the last 2 years.  One thousand two 
hundred [1200] patients underwent Endoscopy 
[OGD] during the period May 2014 to May 2016.  
Forty Four [44] patients seen over the 2 years period 
had gastric cancer confirmed histologically. Twenty 
seven [27] were male and seventeen [17] were 
females, giving female to male ratio 1:1.8  The 
patients sent for OGD in the clinic were referrals from 
all over the country.  
The age range for those with Cancer was 23years to 
85 years. Mean age for the 44 cancer patients was 
58.3yrs. Mean age for males was 61.8 years and that 
form females was 53.5 years.  Below are tables and 
diagram to show age distribution by gender, cancer 
type by histology and distribution by age and gender 
and comparison in percentages by age and anatomical 
sites. 
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Fig. 1: Age distribution by gender 
Majority of patients were aged between 41-70yrs. 
 
Fig. 2 Histological and types of cancer by percentage 
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Fig 3:  Distribution of cancer by gender and histology type 
 
Fig 4: Gastric Cancer [Percentage]:  Age Distribution and Anatomical Site. 
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Fig 5: Gastric Cancer distribution [Percentage]:  Anatomical site and Gender 
Discussions 
Our study shows most patients were in the 5th and 6th 
decades of life.  It also shows   59% of the cancer 
cases were of diffuse type and 34% were of the 
intestinal type as shown in diagram 2.  These figures 
compare with those published by Polkowski W. and 
colleagues 54% and 32% respectively. [17] 
However, the females appeared to be affected earlier 
than males as shown in figure 1.  Intestinal gastric 
adenocarcinoma also tended to affect more males 
[37.3%] than females [29.4%].  Diffuse gastric 
adenocarcinoma also affected more males than 
females but the difference was small 55.5% vs 
64.7%.  This pattern of cancer appears to occur in 
similar fashion in the United States of America across 
all races [18] and Scandinavia [19].  Apart from 
cancer male predominance, the cancer occurrence 
peaked in the 51 – 60 year old group males and 41 – 
50 years old group in females.  The intestinal type of 
gastric cancer has been on decline while the diffuse 
type is on the rise [20-24].  Diffuse gastric cancer has 
a poorer prognosis and affects all age groups much 
more that intestinal type as shown by our results.  
Adachi Y and colleagues also show similar findings 
[22] 
Adenocarcinoma of the gastric cardia affected 37% 
of the patients with almost all patients being 50yrs or 
older compared to non-cardia cancer patients with 
distribution of 33% being 50yrs of age or less.  
However, the ratio between diffuse gastric cancers in 
the cardia are about equal.  These findings tend to 
agree with other published data from other parts of 
the World. 
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Though our sample size is small, we believe this 
shows important features about cancer of the stomach 
in our set up.  These include male predominance, 
women are affected earlier than men by about 1 
decade and the predominant type is diffuse gastric 
adenocarcinoma. 
It is important to identify the important aetiological 
factors.  Early diagnosis is the key to optimal 
outcomes in treatment. 
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